Search

everythinglearnresearchcommunity

for

Search:↓

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Dutasteride reduces DHT more effectively than finasteride.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Finasteride doesn't affect ovulation in normal women.

Medroxyprogesterone acetate improved sleep apnea symptoms in some obese patients.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

Finasteride may effectively reduce Tourette's syndrome symptoms and improve life quality.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

Some birth control pills increase blood clot risk; use them for specific conditions only.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

The new compound may be a safer alternative to finasteride for prostate protection.

Dutasteride is approved to help manage prostate enlargement.

Finasteride may help prevent prostate cancer.

Hormonal contraceptives and therapies regulate organ functions and treat various conditions.

LGD1069 effectively prevents breast tumors in mice without toxicity.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Cyproterone acetate effectively treats sexual disorders by reducing sexual functions and is generally well-tolerated.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Isotretinoin is a preferred treatment for severe acne, often leading to long-term improvement, but requires careful monitoring due to potential side effects.

Testosterone with dutasteride improves muscle strength and body composition in trans men.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Combining 5α-reductase and aromatase inhibitors may better reduce estrogen levels.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.